BTK, a crucial non-receptor tyrosine kinase in hematopoietic cells, is integral to pathways such as the B-cell receptor and Toll-like receptor signaling.314 Dysregulated BTK expression is pivotal in B-cell malignancies and autoimmune diseases, making it a prime target for anticancer therapies. Here, BTK is linked to autoimmune disease.